Literature DB >> 29346717

Anterior cruciate ligament tear induces a sustained loss of muscle fiber force production.

Jonathan P Gumucio1,2, Kristoffer B Sugg1,2,3, Elizabeth R Sibilsky Enselman1, Alexis C Konja1, Logan R Eckhardt1, Asheesh Bedi1,4, Christopher L Mendias1,2,4.   

Abstract

INTRODUCTION: Patients with anterior cruciate ligament (ACL) tears have persistent quadriceps strength deficits that are thought to be due to altered neurophysiological function. Our goal was to determine the changes in muscle fiber contractility independent of the ability of motor neurons to activate fibers.
METHODS: We obtained quadriceps biopsies of patients undergoing ACL reconstruction, and additional biopsies 1, 2, and 6 months after surgery. Muscles fiber contractility was assessed in vitro, along with whole muscle strength testing.
RESULTS: Compared with controls, patients had a 30% reduction in normalized muscle fiber force at the time of surgery. One month later, the force deficit was 41%, and at 6 months the deficit was 23%. Whole muscle strength testing demonstrated similar trends. DISCUSSION: While neurophysiological dysfunction contributes to whole muscle weakness, there is also a reduction in the force generating capacity of individual muscle cells independent of alpha motor neuron activation. Muscle Nerve, 2018.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  anterior cruciate ligament; anterior cruciate ligament tear; isokinetic strength; muscle atrophy; muscle contractility; rehabilitation

Year:  2018        PMID: 29346717      PMCID: PMC6051936          DOI: 10.1002/mus.26075

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  20 in total

1.  Understanding and preventing noncontact anterior cruciate ligament injuries: a review of the Hunt Valley II meeting, January 2005.

Authors:  Letha Y Griffin; Marjorie J Albohm; Elizabeth A Arendt; Roald Bahr; Bruce D Beynnon; Marlene Demaio; Randall W Dick; Lars Engebretsen; William E Garrett; Jo A Hannafin; Tim E Hewett; Laura J Huston; Mary Lloyd Ireland; Robert J Johnson; Scott Lephart; Bert R Mandelbaum; Barton J Mann; Paul H Marks; Stephen W Marshall; Grethe Myklebust; Frank R Noyes; Christopher Powers; Clarence Shields; Sandra J Shultz; Holly Silvers; James Slauterbeck; Dean C Taylor; Carol C Teitz; Edward M Wojtys; Bing Yu
Journal:  Am J Sports Med       Date:  2006-09       Impact factor: 6.202

2.  ACL injury reduces satellite cell abundance and promotes fibrogenic cell expansion within skeletal muscle.

Authors:  Christopher S Fry; Darren L Johnson; Mary Lloyd Ireland; Brian Noehren
Journal:  J Orthop Res       Date:  2017-01-15       Impact factor: 3.494

3.  Pharmacological inhibition of myostatin protects against skeletal muscle atrophy and weakness after anterior cruciate ligament tear.

Authors:  Caroline Nw Wurtzel; Jonathan P Gumucio; Jeremy A Grekin; Roger K Khouri; Alan J Russell; Asheesh Bedi; Christopher L Mendias
Journal:  J Orthop Res       Date:  2017-02-15       Impact factor: 3.494

4.  Rotator cuff tear reduces muscle fiber specific force production and induces macrophage accumulation and autophagy.

Authors:  Jonathan P Gumucio; Max E Davis; Joshua R Bradley; Patrick L Stafford; Corey J Schiffman; Evan B Lynch; Dennis R Claflin; Asheesh Bedi; Christopher L Mendias
Journal:  J Orthop Res       Date:  2012-06-13       Impact factor: 3.494

5.  Factors involved in the development of osteoarthritis after anterior cruciate ligament surgery.

Authors:  Susan L Keays; Peter A Newcombe; Joanne E Bullock-Saxton; Margaret I Bullock; Anthony C Keays
Journal:  Am J Sports Med       Date:  2010-01-05       Impact factor: 6.202

6.  Sex and limb differences in hip and knee kinematics and kinetics during anticipated and unanticipated jump landings: implications for anterior cruciate ligament injury.

Authors:  T N Brown; R M Palmieri-Smith; S G McLean
Journal:  Br J Sports Med       Date:  2009-04-16       Impact factor: 13.800

Review 7.  Neuromuscular consequences of anterior cruciate ligament injury.

Authors:  Christopher D Ingersoll; Terry L Grindstaff; Brian G Pietrosimone; Joseph M Hart
Journal:  Clin Sports Med       Date:  2008-07       Impact factor: 2.182

Review 8.  Maximizing quadriceps strength after ACL reconstruction.

Authors:  Riann M Palmieri-Smith; Abbey C Thomas; Edward M Wojtys
Journal:  Clin Sports Med       Date:  2008-07       Impact factor: 2.182

9.  Reduced muscle fiber force production and disrupted myofibril architecture in patients with chronic rotator cuff tears.

Authors:  Christopher L Mendias; Stuart M Roche; Julie A Harning; Max E Davis; Evan B Lynch; Elizabeth R Sibilsky Enselman; Jon A Jacobson; Dennis R Claflin; Sarah Calve; Asheesh Bedi
Journal:  J Shoulder Elbow Surg       Date:  2014-09-03       Impact factor: 3.019

10.  Local cryotherapy minimally impacts the metabolome and transcriptome of human skeletal muscle.

Authors:  Dylan C Sarver; Kristoffer B Sugg; Nathaniel P Disser; Elizabeth R Sibilsky Enselman; Tariq M Awan; Christopher L Mendias
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

View more
  8 in total

1.  Quadriceps muscle function following anterior cruciate ligament reconstruction: systemic differences in neural and morphological characteristics.

Authors:  Adam S Lepley; Dustin R Grooms; Julie P Burland; Steven M Davi; Jeffrey M Kinsella-Shaw; Lindsey K Lepley
Journal:  Exp Brain Res       Date:  2019-03-09       Impact factor: 1.972

2.  Thigh-Muscle and Patient-Reported Function Early After Anterior Cruciate Ligament Reconstruction: Clinical Cutoffs Unique to Graft Type and Age.

Authors:  David Sherman; Thomas Birchmeier; Christopher M Kuenze; Craig Garrison; Joseph Hannon; James Bothwell; Curtis Bush; Grant E Norte
Journal:  J Athl Train       Date:  2020-08-01       Impact factor: 2.860

3.  Utility of Neuromuscular Electrical Stimulation to Preserve Quadriceps Muscle Fiber Size and Contractility After Anterior Cruciate Ligament Injuries and Reconstruction: A Randomized, Sham-Controlled, Blinded Trial.

Authors:  Michael J Toth; Timothy W Tourville; Thomas B Voigt; Rebecca H Choquette; Bradley M Anair; Michael J Falcone; Mathew J Failla; Jennifer E Stevens-Lapslaey; Nathan K Endres; James R Slauterbeck; Bruce D Beynnon
Journal:  Am J Sports Med       Date:  2020-07-06       Impact factor: 6.202

4.  The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial.

Authors:  Christopher L Mendias; Elizabeth R Sibilsky Enselman; Adam M Olszewski; Jonathan P Gumucio; Daniel L Edon; Maxwell A Konnaris; James E Carpenter; Tariq M Awan; Jon A Jacobson; Joel J Gagnier; Ariel L Barkan; Asheesh Bedi
Journal:  Am J Sports Med       Date:  2020-05-26       Impact factor: 6.202

5.  Skeletal muscle cellular contractile dysfunction after anterior cruciate ligament reconstruction contributes to quadriceps weakness at 6-month follow-up.

Authors:  Timothy W Tourville; Thomas B Voigt; Rebecca H Choquette; Mathew J Failla; Nathan K Endres; James R Slauterbeck; Bruce D Beynnon; Michael J Toth
Journal:  J Orthop Res       Date:  2021-06-20       Impact factor: 3.494

6.  Long-Lasting Impairments in Quadriceps Mitochondrial Health, Muscle Size, and Phenotypic Composition Are Present After Non-invasive Anterior Cruciate Ligament Injury.

Authors:  Steven M Davi; Ahram Ahn; McKenzie S White; Timothy A Butterfield; Kate Kosmac; Oh Sung Kwon; Lindsey K Lepley
Journal:  Front Physiol       Date:  2022-01-28       Impact factor: 4.755

Review 7.  Muscle Atrophy After ACL Injury: Implications for Clinical Practice.

Authors:  Lindsey K Lepley; Steven M Davi; Julie P Burland; Adam S Lepley
Journal:  Sports Health       Date:  2020-08-31       Impact factor: 3.843

8.  Ankle perturbation generates bilateral alteration of knee muscle onset times after unilateral anterior cruciate ligament reconstruction.

Authors:  Patricio A Pincheira; Rony Silvestre; Susan Armijo-Olivo; Rodrigo Guzman-Venegas
Journal:  PeerJ       Date:  2018-07-31       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.